www.occrp.org
Open in
urlscan Pro
78.47.68.36
Public Scan
Submitted URL: https://www.occrp.org/en/27-ccwatch/cc-watch-briefs/18751-florida-lab-owner-to-pay-us-27-million-for-fraudulent-cancer...
Effective URL: https://www.occrp.org/en/daily/18751-florida-lab-owner-to-pay-us-27-million-for-fraudulent-cancer-tests
Submission: On May 28 via manual from US — Scanned from US
Effective URL: https://www.occrp.org/en/daily/18751-florida-lab-owner-to-pay-us-27-million-for-fraudulent-cancer-tests
Submission: On May 28 via manual from US — Scanned from US
Form analysis
1 forms found in the DOMName: mc-embedded-subscribe-form — POST //mailchi.mp/occrp/subscribe-newsletter?campaign=top-button
<form action="//mailchi.mp/occrp/subscribe-newsletter?campaign=top-button" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank" novalidate="">
<div id="mc_embed_signup_scroll">
<h2>Subscribe to our weekly newsletter!</h2>
<p style="margin-bottom: 15px; text-align: center; font-weight: 600;">And get our latest investigations on organized crime and corruption delivered straight to your inbox.<br></p>
<div class="mc-field-group">
<label for="mce-EMAIL">Email Address <span class="asterisk">*</span>
</label>
<input type="email" value="" name="EMAIL" class="required email" id="mce-EMAIL">
</div>
<div id="mce-responses" class="clear">
<div class="response" id="mce-error-response" style="display:none"></div>
<div class="response" id="mce-success-response" style="display:none"></div>
</div> <!-- real people should not fill this in and expect good things - do not remove this or risk form bot signups-->
<div style="position: absolute; left: -5000px;"><input type="text" name="b_8a7b7dd3a0e2c0adfe8fae715_bcc1d53473" tabindex="-1" value=""></div>
<div class="clear">
<input type="submit" value="Subscribe" name="subscribe" class="button" id="mc-embedded-subscribe">
<button class="mfp-close" type="button" title="Close (Esc)">No thanks</button>
</div>
</div>
</form>
Text Content
* Featured: * The Panama Papers * Laundromats * The Pegasus Project * The Pandora Papers * * * * * DESKTOP MENU Donate MOBILE MENU * Navigation * Search * Investigations * Daily * Features * Announcements * Resources * Contact * About Donate * Ru MAIN NAVIGATION, LEFT SIDE * Investigations * Daily * Features * Announcements * Resources * Contact * About * Ru FLORIDA LAB OWNER TO PAY US$27 MILLION FOR FRAUDULENT CANCER TESTS Published: 28 May 2024 Hurt has agreed to pay $27 million for defrauding the U.S. medical system via unnecessary cancer tests. (Photo: Darryl Leja, National Human Genome Research Institute (NIH), Flickr, License) By Henry Pope Share An American medical laboratory owner agreed to pay over US$27 million in restitution for defrauding the federal government’s health insurance program via a kickback scheme that falsified cancer diagnosis and treatment tests. Daniel Hurt, a former owner of multiple cancer research laboratories, pleaded guilty in September 2022 to various offenses including health care fraud, violating the country’s anti-kickback statute, and money laundering. He did this, authorities said, by fraudulently billing Medicare for cancer genomic tests “that were not medically necessary and were procured through illegal kickbacks.” Medicare provides federal health insurance coverage and payments for tens of millions of elderly Americans. Cancer genomics is the study of how changes in a gene’s structure can affect cells which are known to cause cancer. Working with co-conspirators, Hurt solicited kickbacks in exchange for Medicare referrals, in violation of the country’s anti-kickback statute. Prosecutors further said that, from January 2019 to November 2021, he conspired with telemarketers to procure patients for free yet unnecessary cancer tests, the costs of which would then be passed on to the federal government and, by extension, the American taxpayers. “We will not tolerate those who prey on older Americans to defraud Medicare,” said Principal Deputy Assistant Attorney General Brian M. Boynton. Hurt admitted during plea hearings that he defrauded the health care system for thousands of such tests. He also listed laboratories as the billing entity on his reimbursement requests that were not equipped to perform cancer genomic tests. He admitted in September 2022 that the costs of each test exceeded $12,000 per patient; between January 2019 and October 2019, Medicare paid out more than $25 million in unnecessary cancer tests. Millions from this amount were transferred by laboratory staff, at Hurt’s discretion, to bank accounts he controlled. Millions more were used in kickbacks for his co-conspirators. The funds were laundered through sham contracts with his co-conspirators to give authorities the impression they were engaged in legitimate marketing, medical, and referral practices, prosecutors said. “Medicare and Medicaid are two vitally important health care programs that provide critical services to millions of Americans,” said U.S. Attorney Philip R. Sellinger for the District of New Jersey. “Schemes that seek to siphon money from these programs with unnecessary medical tests are especially egregious.” Hurt’s misdeeds were exposed thanks to whistleblower Robert Gerstein, who ran his fraudulent billing operations. Gerstein’s aid to prosecutors will see him rewarded with 17% of the government’s recovery, which amounts to $4.7 million. fraud USA medicare health care cancer genomes * Contact * Privacy Policy * Bypassing Censorship * About * Member Centers * History of OCCRP * Team * Board of Directors * Awards * Our Supporters SUBSCRIBE TO OUR WEEKLY NEWSLETTER! And get our latest investigations on organized crime and corruption delivered straight to your inbox. Email Address * No thanks YOUR COOKIE PREFERENCES We use cookies to improve your experience by storing data about your preferences, your device or your browsing session. We also use cookies to collect anonymized data about your behaviour on our websites, and to understand how we can best improve our services. To find our more details, view our Cookie Policy. Audience Measurement Cookies Essential Cookies Accept my choices Accept All